MENU
+Compare
PEN
Stock ticker: NYSE
AS OF
Jul 30, 04:59 PM (EDT)
Price
$254.28
Change
+$27.13 (+11.94%)
Capitalization
8.64B

PEN Penumbra Forecast, Technical & Fundamental Analysis

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets... Show more

PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PEN with price predictions
Jul 29, 2025

PEN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 11, 2025

PEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where PEN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PEN's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for PEN just turned positive on July 28, 2025. Looking at past instances where PEN's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for PEN moved below the 200-day moving average on July 24, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PEN entered a downward trend on July 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.138) is normal, around the industry mean (24.533). P/E Ratio (93.703) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (8.052) is also within normal values, averaging (43.112).

View a ticker or compare two or three
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 13.22% to 97 cents per share on October 29

Penumbra PEN Stock Earnings Reports
Q3'25
Est.
$0.97
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.16
The last earnings report on July 29 showed earnings per share of 86 cents, beating the estimate of 82 cents. With 1.20M shares outstanding, the current market capitalization sits at 8.64B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEDRX35.38N/A
N/A
Invesco EQV European Equity R
AIVIX17.27N/A
N/A
AB International Value I
FTRNX196.54N/A
N/A
Fidelity Trend
ETIHX35.46N/A
N/A
Eventide Healthcare & Life Sciences I
RICCX63.98-0.06
-0.09%
American Funds Invmt Co of Amer R3

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with ISRG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
+11.91%
ISRG - PEN
42%
Loosely correlated
+1.33%
BSX - PEN
40%
Loosely correlated
+0.27%
MMSI - PEN
36%
Loosely correlated
+0.11%
PODD - PEN
36%
Loosely correlated
+2.33%
NVST - PEN
36%
Loosely correlated
-1.67%
More